Cargando…
Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization
Plasma soluble CD40 ligand (sCD40L) is mainly generated by cleavage of CD40L from the surface of activated platelets, and therefore considered a platelet activation marker. Although the predictive value of sCD40L for ischemic events has been demonstrated in patients with acute coronary syndromes (AC...
Autores principales: | Gremmel, Thomas, Frelinger, Andrew L., Michelson, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523196/ https://www.ncbi.nlm.nih.gov/pubmed/26237513 http://dx.doi.org/10.1371/journal.pone.0134599 |
Ejemplares similares
-
Novel aspects of antiplatelet therapy in cardiovascular disease
por: Gremmel, Thomas, et al.
Publicado: (2018) -
Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2
por: Aloui, Chaker, et al.
Publicado: (2016) -
Soluble CD40 ligand is not solely related to the presence and severity of sepsis
por: Chew, Michelle S, et al.
Publicado: (2011) -
Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation
Publicado: (1993) -
Tunable activation of therapeutic platelet-rich plasma by pulse electric field: Differential effects on clot formation, growth factor release, and platelet morphology
por: Frelinger, Andrew L., et al.
Publicado: (2018)